GlassScriptPhysician profile
Natalie P Gaines
NPI 1376855312
$7,325.43
in general payments reported to CMS, 2019-2025
37 companies · $1,967 in 2025
The $1,967 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Urology) provider received nationally (typical 2025 total: $782).
See the full distribution for Urogynecology and Reconstructive Pelvic Surgery (Urology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $690 · 2020: $1,574 · 2021: $564 · 2022: $1,022 · 2023: $1,207 · 2024: $301 · 2025: $1,967.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,690 · Travel and Lodging: $785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,690.03 |
| Travel and Lodging | $785.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,035.96 | 2021-2025 | Altaviva, Interstim |
| Cipla USA INC. | $1,302.00 | 2020 | |
| Astellas Pharma US INC | $737.47 | 2019-2025 | Myrbetriq, Xtandi |
| Dendreon Pharmaceuticals LLC | $341.07 | 2020-2025 | Provenge |
| Coloplast Corp | $299.53 | 2019-2023 | Altis, Speedicath, Restorelle |
| Medtronic USA, INC. | $261.32 | 2019 | |
| Myriad Genetic Laboratories, INC. | $242.12 | 2020-2025 | Prolaris, Myrisk |
| Sumitomo Pharma America, INC. | $233.54 | 2023-2025 | Gemtesa |
| Abbvie INC. | $206.87 | 2021-2025 | |
| Valencia Technologies Corporation | $178.20 | 2023-2024 | Ecoin Device Kit |
| Janssen Biotech, INC. | $172.48 | 2022-2025 | Erleada |
| Pfizer INC. | $161.08 | 2022-2024 | |
| Urogen Pharma, INC. | $142.52 | 2022-2025 | |
| Intuitive Surgical, INC. | $96.87 | 2022 | |
| Axonics, INC. | $96.81 | 2022-2023 | Axonics |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $89.82 | 2021-2022 | |
| Teleflex LLC | $73.98 | 2021-2025 | Barrigel, Urolift |
| Boston Scientific Corporation | $71.99 | 2019-2025 | Spaceoar Vue System - 10ml, Bulkamid, Axonics |
| Sun Pharmaceutical Industries INC. | $69.56 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $60.82 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $51.86 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $43.80 | 2025 | |
| Allergan, INC. | $43.74 | 2020-2021 | |
| Amgen INC. | $41.03 | 2021-2022 | |
| Olympus America INC. | $39.94 | 2023-2025 | Soltive, Itind System |
| Blue Earth Diagnostics | $29.56 | 2019-2021 | |
| Laborie Medical Technologies Corp. | $27.01 | 2022 | |
| Myovant Sciences INC. | $25.32 | 2021 | |
| Integra Lifesciences Corporation | $22.73 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Accord Healthcare, INC. | $20.35 | 2025 | |
| Coopersurgical, INC. | $19.28 | 2023 | Advincula Delineator Uterine Manipulator |
| Bayer Healthcare Pharmaceuticals INC. | $16.13 | 2025 | |
| Alnylam Pharmaceuticals INC. | $15.86 | 2021 | |
| 180 Medical, INC. | $14.34 | 2019 | |
| Cycle Pharmaceuticals INC | $13.75 | 2025 | Venxxiva |
| Antares Pharma, INC. | $13.73 | 2022 | |
| Therapeuticsmd, INC. | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Gaines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.